0 items USD 0.00Search
Your search for "Drug Discovery" gave back 20 results.
Over the last two decades, the Pharmaceutical industry has seen a radical change. The unprecedented downsizing of the internal discovery of big...
颁补迟补濒辞驳:听
IQ4I
May 2021
Price: USD 7,200.00
鈥淣on-alcoholic steatohepataitis (NASH) Pipeline Analysis鈥� gives comprehensive insights on the various drugs being developed for the treatment of NASH...
IQ4I
October 2019
Price: USD 3,600.00
Targeted Protein Degradation by Novel PROTACs and Molecular Glues 2020: a landscape analysis of companies, technologies, targets, investors and...
颁补迟补濒辞驳:听
La Merie Publishing
May 2020
Price: USD 2,350.00
鈥淟utetium-177 Global 麻豆原创 Analysis鈥� gives comprehensive insights on the various Lu-177 based drugs being developed for the treatment of GEP-NET,...
IQ4I
February 2020
Price: USD 3,600.00
This report bundle includes four reports about novel cancer targets which have in common a compelling target expression profile with a low risk of on...
颁补迟补濒辞驳:听
La Merie Publishing
July 2022
Price: USD 2,000.00
Claudin 6 (CLDN6) is a compelling tumor antigen. The tetraspan membrane protein is a member of the claudin family of tight junction proteins. CLDN6...
颁补迟补濒辞驳:听
La Merie Publishing
May 2022
Price: USD 560.00
This report provides a landscape description and analysis of chimeric antigen receptor-macrophage (CAR-M) platform technologies and stakeholders from...
颁补迟补濒辞驳:听
La Merie Publishing
February 2023
Price: USD 2,000.00
Cadherins are a family of glycoproteins responsible for calcium ion鈥揹ependent cell adhesion. There are more than 100 types of cadherins in humans,...
颁补迟补濒辞驳:听
La Merie Publishing
May 2022
Price: USD 450.00
This report evaluates G-protein鈥揷oupled receptor family C group 5 member D (GPRC5D) from an industry perspective for its suitability as a tumor-...
颁补迟补濒辞驳:听
La Merie Publishing
July 2022
Price: USD 670.00
This report evaluates Receptor tyrosine kinase-like Orphan Receptor 1 (ROR1) from an industry perspective for its suitability as a tumor-specific...
颁补迟补濒辞驳:听
La Merie Publishing
June 2022
Price: USD 1,170.00
Pharmaceutical excipients are inactive substances in the drug which helps in modulating solubility, bioavailability, and stability of active...
IQ4I
July 2019
Price: USD 4,950.00
COVID-19 Vaccines - Mass Rollouts begin but hurdles are halting progress Summary 2021 has started tougher than many expected with new variants...
麻豆原创Line
January 2021
Price: USD 995.00
Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline Summary GBI Research鈥檚 latest report, 鈥淚nnovation...
CBR Pharma Insights
May 2017
Price: USD 2,995.00
Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties Faced by products...
颁补迟补濒辞驳:听
CBR Pharma Insights
January 2018
Price: USD 2,995.00
Asia Pacific active pharmaceutical ingredients (API) market will grow by 9.0% annually with a total addressable market cap of $636.1 billion over...
Grace 麻豆原创 Data
February 2021
Price: USD 2,480.00
听
